NYSEAMERICAN:YCBD cbdMD (YCBD) Stock Price, News & Analysis $0.34 -0.01 (-3.99%) As of 01:08 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsOwnershipSEC Filings About cbdMD Stock (NYSEAMERICAN:YCBD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get cbdMD alerts:Sign Up Key Stats Today's Range$0.33▼$0.3650-Day Range$0.36▼$0.6052-Week Range$0.33▼$2.56Volume169,323 shsAverage Volume916,199 shsMarket Capitalization$3.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview cbdMD, Inc. (NYSE American: YCBD) is a consumer health and wellness company that develops, markets and sells hemp-derived cannabinoid products. Its offerings have included cannabidiol (CBD) oils and tinctures, gummies and other ingestible products, capsules, creams and lotions, as well as products formulated for sleep, recovery and general wellness. The company also markets CBD products for pets and has expanded its portfolio to include additional cannabinoid-based and functional wellness products. cbdMD sells primarily through its direct-to-consumer e-commerce channels and through retail and distribution partners, with a principal focus on the U.S. market. The business was formerly associated with Level Brands, Inc. and adopted the cbdMD, Inc. name as its operations became centered on the cbdMD brand. The company’s product portfolio and distribution strategy have evolved with changes in the hemp and cannabinoid markets. Specific current leadership details are not included here because reliable, up-to-date information was not available.AI Generated. May Contain Errors. Read More cbdMD Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreYCBD MarketRank™: 0.366640337015 of 5 starscbdMD scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingcbdMD has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoveragecbdMD has only been the subject of 1 research reports in the past 90 days.Read more about cbdMD's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatiocbdMD has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about cbdMD's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.83% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.39, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently increased by 19.56%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldcbdMD does not currently pay a dividend.Dividend GrowthcbdMD does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A Search Interest1 people have searched for YCBD on MarketBeat in the last 30 days. MarketBeat Follows1 people have added cbdMD to their MarketBeat watchlist in the last 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, cbdMD insiders have not sold or bought any company stock.Percentage Held by Insiders6.50% of the stock of cbdMD is held by insiders.Percentage Held by Institutions7.18% of the stock of cbdMD is held by institutions.Read more about cbdMD's insider trading history. Receive YCBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. YCBD Stock News HeadlinesReserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging ConversationSeptember 24, 2026 | prnewswire.comCbdMD Enters Definitive Agreement To Acquire Twinlab Brands To Expand Wellness Platform; Stock UpSeptember 2, 2026 | rttnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 13 at 1:00 AM | Stansberry Research (Ad)cbdMD agrees to acquire Twinlab BrandsSeptember 2, 2026 | seekingalpha.comcbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity WellnessSeptember 2, 2026 | prnewswire.comcbdMD, Inc. (YCBD) Q3 2026 Earnings Call TranscriptAugust 13, 2026 | seekingalpha.comcbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026August 13, 2026 | prnewswire.comcbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter ResultsAugust 10, 2026 | prnewswire.comSee More Headlines YCBD Stock Analysis - Frequently Asked Questions How have YCBD shares performed this year? cbdMD's stock was trading at $1.35 at the start of the year. Since then, YCBD stock has decreased by 73.7% and is now trading at $0.3550. How were cbdMD's earnings last quarter? cbdMD, Inc. (NYSEAMERICAN:YCBD) posted its quarterly earnings data on Thursday, August, 13th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.03) by $0.08. The business had revenue of $5.55 million for the quarter, compared to the consensus estimate of $5.69 million. cbdMD had a negative net margin of 13.80% and a negative trailing twelve-month return on equity of 34.26%. Read the conference call transcript. When did cbdMD's stock split? Shares of cbdMD reverse split on Wednesday, May 7th 2025.The 1-8 reverse split was announced on Monday, April 21st 2025. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 6th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of cbdMD? Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of cbdMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that cbdMD investors own include Village Farms International (VFF), Tilray Brands (TLRY), NVIDIA (NVDA), Roku (ROKU), Organigram Global (OGI), Bristol Myers Squibb (BMY) and Bionano Genomics (BNGO). Company Calendar Last Earnings8/13/2026Today10/13/2026Next Earnings (Estimated)12/18/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 YCBD's financial health is in the Red zone, according to TradeSmith. YCBD has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorConsumer Staples Industry Personal Care Products Sub-IndustryPersonal Care Products Current SymbolNYSEAMERICAN:YCBD CIK1644903 Webwww.cbdmd.com Phone(704) 445-3060FaxN/AEmployees42Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.04 million Net Margins-13.80% Pretax Margin-13.80% Return on Equity-34.26% Return on Assets-24.27% Debt Debt-to-Equity RatioN/A Current Ratio2.50 Quick Ratio1.43 Sales & Book Value Annual Sales$19.19 million Price / Sales0.20 Cash FlowN/A Price / Cash FlowN/A Book Value$0.81 per share Price / Book0.42Miscellaneous Outstanding Shares11,200,000Free Float10,477,000Market Cap$3.82 million OptionableNot Optionable Beta2.24 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSEAMERICAN:YCBD) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding cbdMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share cbdMD With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YCBD Stock Alerts